Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Revive Meds
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict72/ 100
Grade C · #111Revive Meds
The most transparent supply chain of the five and the least transparent pricing, with real costs held back until you have finished a health intake.
Visit Revive MedsThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 72/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Revive Meds still earns its place — people who care more about knowing which pharmacy and which physician are behind the vial than about seeing a price up front.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results76
92
Real-world results76
97Price honesty60
97
Price honesty60
96Prescriber access84
96
Prescriber access84
88Formulary choice62
88
Formulary choice62
95Cancellation fairness82
95
Cancellation fairness82
93Member support72
93
Member support72
Price, coverage & features
| Metric | CoreAge Rx | Revive Meds |
|---|---|---|
| Verdict Score | 94/100 | 72/100 |
| Grade | A | C |
| Semaglutide | $149/mo | $369/mo |
| Tirzepatide | $349/mo | $459/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Revive Meds
What we like
- Names all six of its 503A compounding pharmacies: Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills
- Names two prescribing physicians with NPI numbers, Dr HirenKumar Italia MD and Dr David Mansour DO
- No subscription at all. 'No monthly subscriptions, no sign-up fees, no commitments. Pay only for what you order'
- Flat pricing per drug per term with no dose tiers, so titrating up does not raise the bill
- Free shipping on every order, all 50 states, and HSA/FSA eligible via a Medical Necessity Letter
The caveats
- Compounded semaglutide and tirzepatide, each with B12, are not FDA-approved finished products
- No public price list. Real pricing appears only at the medication-selection step after a full health intake and account creation
- The one public figure, 'As low as $199 per month' on /semaglutide, carries no term and is a multi-month prepay rate, not a month-to-month one
- Month-to-month is the most expensive of this group at roughly $369 semaglutide and $459 tirzepatide; the low rates need 6 to 12 months paid upfront
- No LegitScript certification or seal displayed
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
People who care more about knowing which pharmacy and which physician are behind the vial than about seeing a price up front.
Visit Revive Meds Read the full Revive Meds review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for Revive Meds does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.